Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

COT

Cotinga Pharmaceuticals (COT)

Cotinga Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:COT
DateTimeSourceHeadlineSymbolCompany
15/10/202023:01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
15/10/202022:55PR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
08/11/201908:10PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - COTTSXV:COTCotinga Pharmaceuticals Inc
08/11/201908:09PR Newswire (Canada)IIROC Trading Resumption - COTTSXV:COTCotinga Pharmaceuticals Inc
07/10/201923:13PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
07/10/201923:12PR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
25/07/201406:20Marketwired CanadaCritical Outcome Technologies Reports Year-End Financial and Operating ResultsTSXV:COTCotinga Pharmaceuticals Inc
23/06/201423:00MarketwiredCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
23/06/201423:00Marketwired CanadaCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
17/06/201423:00MarketwiredCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
17/06/201423:00Marketwired CanadaCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
16/06/201423:00Marketwired CanadaCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
16/06/201423:00MarketwiredCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
14/06/201409:42Marketwired CanadaCritical Outcome Technologies Inc.: SeeThruEquity Initiates Research CoverageTSXV:COTCotinga Pharmaceuticals Inc
13/06/201423:00MarketwiredCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
13/06/201423:00Marketwired CanadaCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
04/06/201423:00MarketwiredCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
04/06/201423:00Marketwired CanadaCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
28/05/201406:48Marketwired CanadaCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
28/05/201406:48MarketwiredCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
27/05/201423:00MarketwiredCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
27/05/201423:00Marketwired CanadaCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
22/05/201423:00Access WireSeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014TSXV:COTCotinga Pharmaceuticals Inc
01/05/201422:48MarketwiredFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
01/05/201422:48Marketwired CanadaFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
15/04/201406:30Marketwired CanadaCritical Outcome Technologies Announces Warrant IssuanceTSXV:COTCotinga Pharmaceuticals Inc
05/04/201400:00MarketwiredCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
05/04/201400:00Marketwired CanadaCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
15/03/201400:00MarketwiredCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
15/03/201400:00Marketwired CanadaCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
 Showing the most relevant articles for your search:TSXV:COT